Virologic determinants of breast milk transmission of HIV-1

Advances in Experimental Medicine and Biology

Volumn 743, Issue , 2012, Pages 69-80

  Fiscus, Susan A ^a   Aldrovandi, Grace M ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; EMTRICITABINE; ENVELOPE PROTEIN; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; PLACEBO; RITONAVIR; TENOFOVIR; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ARTICLE; BREAST FEEDING; BREAST MILK; CELL COMPARTMENTALIZATION; DRUG EFFECT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MASTITIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRAL TROPISM; VIRUS CELL INTERACTION; VIRUS CLASSIFICATION; VIRUS DETECTION; VIRUS LOAD; VIRUS MUTATION; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS 1; PNEUMOCYSTIS;

EID: 84859902784     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-2251-8_5     Document Type: Article

References (133)

1. Ziegler JB, Cooper DA, Johnson RO, Gold J (1985) Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet 1:896-898
2. Thiry L, Sprecher-Goldberger S, Jonckheer T et al (1985) Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers. Lancet 2:891-892
3. Nduati R, John G, Mbori-Ngacha D et al (2000) Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 283:1167-1174
4. Kuhn L (2010) Milk mysteries: why are women who exclusively breast-feed less likely to transmit HIV during breast-feeding? Clin Infect Dis 50:770-772
5. Dunn DT, Newell ML, Ades AE, Peckham CS (1992) Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 340:585-588
6. Richardson BA, John-Stewart GC, Hughes JP et al (2003) Breast-milk infectivity in human immunodeficiency virus type 1-infected mothers. J Infect Dis 187:736-740
7. Gray L, Fiscus S, Shugars D (2007) HIV-1 variants from a perinatal transmission pair demonstrate similar genetic and replicative properties in tonsillar tissues and peripheral blood mononuclear cells. AIDS Res Hum Retroviruses 23:1095-1104
8. Vogt MW, Witt DJ, Craven DE et al (1986) Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS. Lancet 1:525-527
9. Southern SO (1998) Milk-borne transmission of HIV. Characterization of productively infected cells in breast milk and interactions between milk and saliva. J Hum Virol 1:328-337
10. Toniolo A, Serra C, Conaldi PG, Basolo F, Falcone V, Dolei A (1995) Productive HIV-1 infection of normal human mammary epithelial cells. AIDS 9:859-866
11. Lyimo MA, Howell AL, Balandya E, Eszterhas SK, Connor RI (2009) Innate factors in human breast milk inhibit cell-free HIV-1 but not cell-associated HIV-1 infection of CD4+ cells. J Acquir Immune Defic Syndr 51:117-124
12. Habte HH, de Beer C, Lotz ZE, Tyler MG, Kahn D, Mall AS (2008) Inhibition of human immunodeficiency virus type 1 activity by purified human breast milk mucin (MUC1) in an inhibition assay. Neonatology 93:162-170
13. Habte HH, Kotwal GJ, Lotz ZE et al (2007) Antiviral activity of purified human breast milk mucin. Neonatology 92:96-104
14. Villamor E, Koulinska IN, Furtado J et al (2007) Long-chain n-6 polyunsaturated fatty acids in breast milk decrease the risk of HIV transmission through breastfeeding. Am J Clin Nutr 86:682-689
15. Viveros-Rogel M, Soto-Ramirez L, Chaturvedi P, Newburg DS, Ruiz-Palacios GM (2004) Inhibition of HIV-1 infection in vitro by human milk sulfated glycolipids and glycosaminoglycans. Adv Exp Med Biol 554:481-487
16. Baron S, Poast J, Richardson CJ, Nguyen D, Cloyd M (2000) Oral transmission of human immunodeficiency virus by infected seminal fluid and milk: a novel mechanism. J Infect Dis 181:498-504
17. Martin V, Maldonado A, Fernandez L, Rodriguez JM, Connor RI (2010) Inhibition of human immunodeficiency virus type 1 by lactic acid bacteria from human breastmilk. Breastfeed Med 5:153-158
18. Buransin P, Kunakorn M, Petchlai B et al (1993) Detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in breast milk and colostrum of seropositive mothers. J Med Assoc Thai 76:41-44
19. Guay LA, Hom DL, Mmiro F et al (1996) Detection of human immunodeficiency virus type 1 (HIV-1) DNA and p24 antigen in breast milk of HIV-1-infected Ugandan women and vertical transmission. Pediatrics 98:438-444
20. Nduati RW, John GC, Richardson BA et al (1995) Human immunodeficiency virus type 1-infected cells in breast milk: association with immunosuppression and vitamin A deficiency. J Infect Dis 172:1461-1468
21. Ruff AJ, Coberly J, Halsey NA et al (1994) Prevalence of HIV-1 DNA and p24 antigen in breast milk and correlation with maternal factors. J Acquir Immune Defic Syndr 7:68-73
22. Van de Perre P, Simonon A, Hitimana DG et al (1993) Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet 341:914-918
23. Gantt S, Shetty AK, Seidel KD et al (2007) Laboratory indicators of mastitis are not associated with elevated HIV-1 DNA loads or predictive of HIV-1 RNA loads in breast milk. J Infect Dis 196:570-576
24. Koulinska IN, Villamor E, Chaplin B et al (2006) Transmission of cell-free and cell-associated HIV-1 through breast-feeding. J Acquir Immune Defic Syndr 41:93-99
25. Rousseau CM, Nduati RW, Richardson BA et al (2004) Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J Infect Dis 190:1880-1888
26. Kantarci S, Koulinska IN, Aboud S, Fawzi WW, Villamor E (2007) Subclinical mastitis, cell-associated HIV-1 shedding in breast milk, and breast-feeding transmission of HIV-1. J Acquir Immune Defic Syndr 46:651-654
27. Villamor E, Koulinska IN, Aboud S et al (2010) Effect of vitamin supplements on HIV shedding in breast milk. Am J Clin Nutr 92:881-886
28. Vonesch N, Sturchio E, Humani AC, Fei PC, Coszena D, Caprilli F, Pezzella M (1992) Detection of HIV-1 genome in leukocytes of human colostrum from anti-HIV-1 seropositive mothers. AIDS Res Hum Retroviruses 8:1283-1287
29. John GC, Nduati RW, Mbori-Ngacha DA et al (2001) Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis 183:206-212
30. Hoffman IF, Martinson FE, Stewart PW et al (2003) Human immunodeficiency virus type 1 RNA in breast-milk components. J Infect Dis 188:1209-1212
31. Lewis P, Nduati R, Kreiss JK et al (1998) Cell-free human immunodeficiency virus type 1 in breast milk. J Infect Dis 177:34-39
32. Pillay K, Coutsoudis A, York D, Kuhn L, Coovadia HM (2000) Cell-free virus in breast milk of HIV-1-seropositive women. J Acquir Immune Defic Syndr 24:330-336
33. Rousseau CM, Nduati RW, Richardson BA et al (2003) Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J Infect Dis 187:741-747
34. Semba RD, Kumwenda N, Hoover DR et al (1999) Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 180:93-98
35. Willumsen JF, Filteau SM, Coutsoudis A et al (2003) Breastmilk RNA viral load in HIV-infected South African women: effects of subclinical mastitis and infant feeding. AIDS 17:407-414
36. Lunney KM, Iliff P, Mutasa K et al (2010) Associations between breast milk viral load, mastitis, exclusive breastfeeding, and postnatal transmission of HIV. Clin Infect Dis 50:762-769
37. Phiri W, Kasonka L, Collin S et al (2006) Factors influencing breast milk HIV RNA viral load among Zambian women. AIDS Res Hum Retroviruses 22:607-614
38. Semrau K, Ghosh M, Kankasa C et al (2008) Temporal and lateral dynamics of HIV shedding and elevated sodium in breast milk among HIV-positive mothers during the first 4 months of breast-feeding. J Acquir Immune Defic Syndr 47:320-328
39. Petitjean G, Becquart P, Tuaillon E et al (2007) Isolation and characterization of HIV-1-infected resting CD4+ T lymphocytes in breast milk. J Clin Virol 39:1-8
40. Neveu D, Viljoen J, Bland RM et al (2011) Cumulative exposure to cell-free HIV in breast milk, rather than feeding pattern per se, identifies postnatally infected infants. Clin Infect Dis 52:819-825
41. Chung MH, Kiarie JN, Richardson BA et al (2007) Independent effects of nevirapine prophylaxis and HIV-1 RNA suppression in breast milk on early perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 46:472-478
42. Willumsen JF, Newell ML, Filteau SM et al (2001) Variation in breastmilk HIV-1 viral load in left and right breasts during the first 3 months of lactation. AIDS 15:1896-1898
43. Thea DM, Aldrovandi G, Kankasa C et al (2006) Post-weaning breast milk HIV-1 viral load, blood prolactin levels and breast milk volume. AIDS 20:1539-1547
44. Benaboud S, Pruvost A, Coffie PA et al (2011) Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote dIvoire, in the ANRS 12109 TEmAA Study, step 2. Antimicrob Agents Chemother 55:1315-1317
45. Schneider S, Peltier A, Gras A et al (2008) Efavirenz in human breast milk, mothers, and newborns plasma. J Acquir Immune Defic Syndr 48:450-454
46. Shapiro RL, Holland DT, Capparelli E et al (2005) Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment. J Infect Dis 192:720-727
47. Colebunders R, Hodossy B, Burger D et al (2005) The effect of highly active antiretroviral treatment on viral load and antiretroviral drug levels in breast milk. AIDS 19:1912-1915
48. Manigart O, Crepin M, Leroy V et al (2004) Effect of perinatal zidovudine prophylaxis on the evolution of cellfree HIV-1 RNA in breast milk and on postnatal transmission. J Infect Dis 190:1422-1428
49. Mirochnick M, Thomas T, Capparelli E et al (2009) Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy. Antimicrob Agents Chemother 53:1170-1176
50. Corbett A, Martinson F, Rezk N, Kashuba A, Jamieson D, Chasela C, Kayira D, Tegha G, Kamwendo D, van der Horst C, BAN Study Team. (2009) Lopinavir/ritonavir concentrations in breast milk and breast-feeding infants 16th CROI. Montreal, Canada
51. Corbett A, Kashuba A, Rezk N, Jamieson D, Chasela C, Hyde L, Tegha G, Joaki G, Kamwendo D, van der Horst C, BAN Study Team (2008) Antiretroviral drug concentrations in breast milk and breastfeeding infants. 15th CROI. Boston, MA
52. Rossenkhan R, Ndungu T, Sebunya TK et al (2009) Temporal reduction of HIV type 1 viral load in breast milk by single-dose nevirapine during prevention of MTCT. AIDS Res Hum Retroviruses 25:1261-1264
53. Chung MH, Kiarie JN, Richardson BA, Lehman DA, Overbaugh J, John-Stewart GC (2005) Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus shortcourse zidovudine. AIDS 19:1415-1422
54. Lehman DA, Chung MH, John-Stewart GC et al (2008) HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission. AIDS 22:1475-1485
55. Giuliano M, Guidotti G, Andreotti M et al (2007) Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program. J Acquir Immune Defic Syndr 44:286-291
56. Shapiro RL, Ndungu T, Lockman S et al (2005) Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk. J Infect Dis 192:713-719
57. Alfsen A, Yu H, Magerus-Chatinet A, Schmitt A, Bomsel M (2005) HIV-1-infected blood mononuclear cells form an integrin- and agrin-dependent viral synapse to induce efficient HIV-1 transcytosis across epithelial cell monolayer. Mol Biol Cell 16:4267-4279
58. Lagaye S, Derrien M, Menu E et al (2001) Cell-to-cell contact results in a selective translocation of maternal human immunodeficiency virus type 1 quasispecies across a trophoblastic barrier by both transcytosis and infection. J Virol 75:4780-4791
59. Lehman DA, Farquhar C (2007) Biological mechanisms of vertical human immunodeficiency virus (HIV-1) transmission. Rev Med Virol 17:381-403
60. Phillips DM (1994) The role of cell-to-cell transmission in HIV infection. AIDS 8:719-731
61. Becquart P, Hocini H, Levy M, Sepou A, Kazatchkine MD, Belec L (2000) Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV. J Infect Dis 181:532-539
62. Bomsel M, Alfsen A (2003) Entry of viruses through the epithelial barrier: pathogenic trickery. Nat Rev Mol Cell Biol 4:57-68
63. Bosire R, John-Stewart GC, Mabuka JM et al (2007) Breast milk alpha-defensins are associated with HIV type 1 RNA and CC chemokines in breast milk but not vertical HIV type 1 transmission. AIDS Res Hum Retroviruses 23:198-203
64. Farquhar C, Mbori-Ngacha DA, Redman MW et al (2005) CC and CXC chemokines in breastmilk are associated with mother-to-child HIV-1 transmission. Curr HIV Res 3:361-369
65. Kuhn L, Trabattoni D, Kankasa C et al (2006) HIV-specific secretory IgA in breast milk of HIV-positive mothers is not associated with protection against HIV transmission among breast-fed infants. J Pediatr 149:611-616
66. Moore JS, Rahemtulla F, Kent LW et al (2003) Oral epithelial cells are susceptible to cell-free and cell-associated HIV-1 infection in vitro. Virology 313:343-353
67. Burkhard MJ, Dean GA (2003) Transmission and immunopathogenesis of FIV in cats as a model for HIV. Curr HIV Res 1:15-29
68. Ruprecht RM, Baba TW, Liska V et al (1999) Oral transmission of primate lentiviruses. J Infect Dis 179(Suppl 3):S408-S412
69. Otsyula MG, Miller CJ, Tarantal AF et al (1996) Fetal or neonatal infection with attenuated simian immunodeficiency virus results in protective immunity against oral challenge with pathogenic SIVmac251. Virology 222:275-278
70. Burkhard MJ, Obert LA, ONeil LL, Diehl LJ, Hoover EA (1997) Mucosal transmission of cell-associated and cell-free feline immunodeficiency virus. AIDS Res Hum Retroviruses 13:347-355
71. ONeil LL, Burkhard MJ, Hoover EA (1996) Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats. J Virol 70:2894-2901
72. Obert LA, Hoover EA (2000) Feline immunodeficiency virus clade C mucosal transmission and disease courses. AIDS Res Hum Retroviruses 16:677-688
73. Howard KE, Burkhard MJ (2007) Mucosal challenge with cell-associated or cell-free feline immunodeficiency virus induces rapid and distinctly different patterns of phenotypic change in the mucosal and systemic immune systems. Immunology 122:571-583
74. Anderson DJ (2010) Finally, a macaque model for cell-associated SIV/HIV vaginal transmission. J Infect Dis 202:333-336
75. Sellon RK, Jordan HL, Kennedy-Stoskopf S, Tompkins MB, Tompkins WA (1994) Feline immunodeficiency virus can be experimentally transmitted via milk during acute maternal infection. J Virol 68:3380-3385
76. Van Rompay KK, Abel K, Lawson JR et al (2005) Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV. J Acquir Immune Defic Syndr 38:124-134
77. Van Rompay KK, Greenier JL, Cole KS et al (2003) Immunization of newborn rhesus macaques with simian immunodeficiency virus (SIV) vaccines prolongs survival after oral challenge with virulent SIVmac251. J Virol 77:179-190
78. Van Rompay KK, Schmidt KA, Lawson JR, Singh R, Bischofberger N, Marthas ML (2002) Topical administration of low-dose tenofovir disoproxil fumarate to protect infant macaques against multiple oral exposures of low doses of simian immunodeficiency virus. J Infect Dis 186:1508-1513
79. Kourtis AP, Bulterys M (2010) Mother-to-child transmission of HIV: pathogenesis, mechanisms and pathways. Clin Perinatol 37:721-737, vii
80. Yamaguchi K, Sugiyama T, Takizawa M, Yamamoto N, Honda M, Natori M (2007) Viability of infectious viral particles of HIV and BMCs in breast milk. J Clin Virol 39:222-225
81. Walter J, Kuhn L, Aldrovandi GM (2008) Advances in basic science understanding of mother-to-child HIV-1 transmission. Curr Opin HIV AIDS 3:146-150
82. Coutsoudis A, Dabis F, Fawzi W et al (2004) Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis 189:2154-2166
83. Miotti PG, Taha TE, Kumwenda NI et al (1999) HIV transmission through breastfeeding: a study in Malawi. JAMA 282:744-749
84. Moodley D, Moodley J, Coovadia H et al (2003) A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 187:725-735
85. Mandelbrot L, Burgard M, Teglas JP et al (1999) Frequent detection of HIV-1 in the gastric aspirates of neonates born to HIV-infected mothers. AIDS 13:2143-2149
86. Coovadia HM, Rollins NC, Bland RM et al (2007) Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet 369:1107-1116
87. Kuhn L, Sinkala M, Kankasa C et al (2007) High uptake of exclusive breastfeeding and reduced early post-natal HIV transmission. PLoS One 2:e1363
88. Olesen R, Wahl A, Denton PW, Garcia JV (2011) Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection. J Reprod Immunol 88:195-203
89. Zhu T, Mo H, Wang N et al (1993) Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261:1179-1181
90. Zhang LQ, MacKenzie P, Cleland A, Holmes EC, Brown AJ, Simmonds P (1993) Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J Virol 67: 3345-3356
91. Wolinsky SM, Wike CM, Korber BT et al (1992) Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 255:1134-1137
92. Derdeyn CA, Decker JM, Bibollet-Ruche F et al (2004) Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 303:2019-2022
93. Keele BF, Giorgi EE, Salazar-Gonzalez JF et al (2008) Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA 105:7552-7557
94. Zhang H, Tully DC, Hoffmann FG, He J, Kankasa C, Wood C (2010) Restricted genetic diversity of HIV-1 subtype C envelope glycoprotein from perinatally infected Zambian infants. PLoS One 5:e9294
95. Margolis L, Shattock R (2006) Selective transmission of CCR5-utilizing HIV-1: the gatekeeper problem resolved? Nat Rev Microbiol 4:312-317
96. Salvatori F, Scarlatti G (2001) HIV type 1 chemokine receptor usage in mother-to-child transmission. AIDS Res Hum Retroviruses 17:925-935
97. Rainwater SM, Wu X, Nduati R et al (2007) Cloning and characterization of functional subtype A HIV-1 envelope variants transmitted through breastfeeding. Curr HIV Res 5:189-197
98. Mulder-Kampinga GA, Simonon A, Kuiken CL et al (1995) Similarity in env and gag genes between genomic RNAs of human immunodeficiency virus type 1 (HIV-1) from mother and infant is unrelated to time of HIV-1 RNA positivity in the child. J Virol 69:2285-2296
99. Satomi M, Shimizu M, Shinya E et al (2005) Transmission of macrophage-tropic HIV-1 by breast-milk macrophages via DC-SIGN. J Infect Dis 191:174-181
100. Heath L, Conway S, Jones L et al (2010) Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission. PLoS One 5:e10213
101. Salazar-Gonzalez JF, Salazar MG, Learn GH et al (2011) Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing. J Virol 85:2751-2763
102. Andreotti M, Galluzzo CM, Guidotti G et al (2009) Comparison of HIV type 1 sequences from plasma, cell-free breast milk, and cell-associated breast milk viral populations in treated and untreated women in Mozambique. AIDS Res Hum Retroviruses 25:707-711
103. Renjifo B, Gilbert P, Chaplin B et al (2004) Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D. AIDS 18:1629-1636
104. Tapia N, Franco S, Puig-Basagoiti F et al (2003) Influence of human immunodeficiency virus type 1 subtype on mother-to-child transmission. J Gen Virol 84:607-613
105. Murray MC, Embree JE, Ramdahin SG, Anzala AO, Njenga S, Plummer FA (2000) Effect of human immunodeficiency virus (HIV) type 1 viral genotype on mother-to-child transmission of HIV-1. J Infect Dis 181: 746-749
106. Yang C, Li M, Newman RD et al (2003) Genetic diversity of HIV-1 in western Kenya: subtype-specific differences in mother-to-child transmission. AIDS 17:1667-1674
107. Renjifo B, Fawzi W, Mwakagile D et al (2001) Differences in perinatal transmission among human immunodeficiency virus type 1 genotypes. J Hum Virol 4:16-25
108. Blackard JT, Renjifo B, Fawzi W et al (2001) HIV-1 LTR subtype and perinatal transmission. Virology 287:261-265
109. Koulinska IN, Villamor E, Msamanga G et al (2006) Risk of HIV-1 transmission by breastfeeding among mothers infected with recombinant and non-recombinant HIV-1 genotypes. Virus Res 120:191-198
110. Eshleman SH, Lie Y, Hoover DR et al (2006) Association between the replication capacity and mother-to-child transmission of HIV-1, in antiretroviral drug-naive Malawian women. J Infect Dis 193:1512-1515
111. Becquart P, Chomont N, Roques P et al (2002) Compartmentalization of HIV-1 between breast milk and blood of HIV-infected mothers. Virology 300:109-117
112. Becquart P, Courgnaud V, Willumsen J, Van de Perre P (2007) Diversity of HIV-1 RNA and DNA in breast milk from HIV-1-infected mothers. Virology 363:256-260
113. Henderson GJ, Hoffman NG, Ping LH et al (2004) HIV-1 populations in blood and breast milk are similar. Virology 330:295-303
114. Gantt S, Carlsson J, Heath L et al (2010) Genetic analyses of HIV-1 env sequences demonstrate limited compartmentalization in breast milk and suggest viral replication within the breast that increases with mastitis. J Virol 84:10812-10819
115. Gray RR, Salemi M, Lowe A et al (2011) Multiple independent lineages of HIV-1 persist in breast milk and plasma. AIDS 25:143-152
116. Andreotti M, Guidotti G, Galluzzo CM et al (2007) Resistance mutation patterns in plasma and breast milk of HIV-infected women receiving highly-active antiretroviral therapy for mother-to-child transmission prevention. AIDS 21:2360-2362
117. Farr SL, Nelson JA, Ngombe TJ et al (2010) Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi. J Acquir Immune Defic Syndr 54:515-523
118. Hudelson SE, McConnell MS, Bagenda D et al (2010) Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration. AIDS 24:557-561
119. Kassaye S, Lee E, Kantor R et al (2007) Drug resistance in plasma and breast milk after single-dose nevirapine in subtype C HIV type 1: population and clonal sequence analysis. AIDS Res Hum Retroviruses 23:1055-1061
120. Lee EJ, Kantor R, Zijenah L et al (2005) Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine. J Infect Dis 192:1260-1264
121. Pilger D, Hauser A, Kuecherer C et al (2011) Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis. Antivir Ther 16:109-113
122. Kroodsma KL, Kozal MJ, Hamed KA, Winters MA, Merigan TC (1994) Detection of drug resistance mutations in the human immunodeficiency virus type 1 (HIV-1) pol gene: differences in semen and blood HIV-1 RNA and proviral DNA. J Infect Dis 170:1292-1295
123. Eron JJ, Vernazza PL, Johnston DM et al (1998) Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission. AIDS 12:F181-F189
124. Kashuba AD, Dyer JR, Kramer LM, Raasch RH, Eron JJ, Cohen MS (1999) Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1. Antimicrob Agents Chemother 43:1817-1826
125. Moorthy A, Gupta A, Bhosale R et al (2009) Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants. PLoS One 4:e4096
126. Shetty AK, Coovadia HM, Mirochnick MM et al (2003) Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months. J Acquir Immune Defic Syndr 34:482-490
127. Richman D, Shih CK, Lowy I et al (1991) Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture. Proc Natl Acad Sci USA 88:11241-11245
128. Richman DD, Havlir D, Corbeil J et al (1994) Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy. J Virol 68:1660-1666
129. Eshleman SH, Mracna M, Guay LA et al (2001) Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). AIDS 15:1951-1957
130. Arrive E, Newell ML, Ekouevi DK et al (2007) Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis. Int J Epidemiol 36:1009-1021
131. Flys T, Nissley DV, Claasen CW et al (2005) Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012. J Infect Dis 192:24-29
132. Church JD, Huang W, Parkin N et al (2009) Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infants. AIDS Res Hum Retroviruses 25:657-663
133. Hammer SM (2005) Single-dose nevirapine and drug resistance: the more you look, the more you find. J Infect Dis 192:1-3